Evidence map›Paper›PMID 25454506›Full record

ArticleAnalytical biochemistry2015

Can your protein be sumoylated? A quick summary and important tips to study SUMO-modified proteins.

Yuxuan Xiao, Daniel Pollack, Edward Nieves, Aby Winchell, Myrasol Callaway, Margarita Vigodner

Abstract read
In one paragraph

Article in Analytical biochemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Inhibition of CDK1 activity by sumoylation.Biochemical and biophysical research communications · 2016
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuxuan XiaoDepartment of Biology, Yeshiva University, New York, NY 10016, USA.
Daniel PollackDepartment of Biology, Yeshiva University, New York, NY 10016, USA.
Edward NievesLaboratory for Macromolecular Analysis and Proteomics, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Aby WinchellDepartment of Biology, Yeshiva University, New York, NY 10016, USA.
Myrasol CallawayLaboratory for Macromolecular Analysis and Proteomics, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Margarita VigodnerDepartment of Biology, Yeshiva University, New York, NY 10016, USA; Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY 10461, USA. Electronic address: vigodner@yu.edu.

Funding

Regulation of spermatogenesis by sumoylationR15HD067944 · NICHD · YESHIVA UNIVERSITY · PI VIGODNER, MARGARITA · 2011 to 2014
$600k
NICHD NIH HHS 1R15HD067944-01A1NICHD NIH HHS R15 HD067944
6 · The paper itself

Abstract

A diverse set of SUMO target proteins has been identified. Therefore, there is a growing interest in studying sumoylation and SUMO interactions in cells. When the sumoylation of a protein or a SUMO interaction is suspected, a standard co-immunoprecipitation analysis using anti-SUMO and anti-target protein antibody is usually performed as a first step. However, the identification of endogenous sumoylated proteins is challenging because of the activity of isopeptidases, and often only a small fraction of a target protein is sumoylated at a given time. Here, we briefly summarize several important steps to ensure a successful co-immunoprecipitation analysis to detect possible sumoylation.

Indexed as

SumoylationImmunoprecipitationProtein Interaction MappingSmall Ubiquitin-Related Modifier ProteinsSmall Ubiquitin-Related Modifier ProteinsCo-immunoprecipitationIn vitro sumoylationIsopeptidasesMass spectrometrySUMOSumoylation

Identifiers

PMID25454506
PMCPMC4404192

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.